Veracyte SVP sells 6,658 shares under 10b5-1 plan
VERACYTE, INC. senior vice president and general counsel Annie McGuire reported selling 6,658 shares of common stock in open-market transactions on March 4, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
VERACYTE, INC. senior vice president and general counsel Annie McGuire reported selling 6,658 shares of common stock in open-market transactions on March 4, 2026. The sales were made under a Rule 10b5-1 trading plan adopted on August 29, 2025.
The reported weighted average sale prices were $35.2936 per share for 4,994 shares and $36.3393 per share for 1,664 shares. After these sales, McGuire directly owned 94,706 shares of Veracyte common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 4,994 | $35.2936 | $176K |
| Sale | Common Stock | 1,664 | $36.3393 | $60K |
Footnotes (3)
- F1. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025.
- F2. Represents weighted average sales price. Sale prices for the transactions range from $35.00 to $35.89. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- F3. Represents weighted average sales price. Sale prices for the transactions range from $36.17 to $36.48. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider stock transaction did Veracyte (VCYT) report for Annie McGuire?
Was the Veracyte (VCYT) insider sale by Annie McGuire under a Rule 10b5-1 plan?
What role does Annie McGuire hold at Veracyte (VCYT) in this Form 4?
How many separate sale transactions did Veracyte (VCYT) disclose for Annie McGuire?
AI-generated analysis. How Rhea-AI works. Not financial advice.